Revenue segments as reported by the company.

Premiums earned, net

Other income

Investment income, net

Direct Contracting revenue

Revenue Segments

Gross Profit, Operating Income, and Net Income as a percentage of Revenue

Operating Margin

Profit Margin

Margins

An operating expense is an expense a business incurs through its normal business operations. Often abbreviated as OPEX.

Net medical claims incurred

Salaries and benefits

General and administrative expenses

Premium deficiency reserve (benefit) expense

Depreciation and amortization

Other expense

Restructuring costs

Impairment of goodwill and other intangible assets

Operating Expenses

Year over year growth in Revenue and Operating Expenses.

Revenue Y/Y

OpEx Y/Y

Growth

Shares outstanding refer to a company's stock currently held by all its shareholders, including share blocks held by institutional investors and restricted shares owned by the company's officers and insiders.

Outstanding Shares

Market Cap

Also known as Price/Sales Ratio. Calculated using Average market cap for the quarter / Annualized quarterly revenue.

Revenue Multiple

Clover Health Investments

Clover Health Investments Corp. provides healthcare insurance services. It uses its proprietary technology platform to collect, structure, and analyze health and behavioral data to improve medical outcomes and lower costs for patients. The company was founded on July 17, 2014 and is headquartered in Franklin, TN.

Earnings data Q1 2021

Earnings data Q2 2021

Earnings data Q3 2021

Earnings data Q4 2021

Earnings data Q1 2022

Earnings data Q2 2022

Earnings data Q3 2022

Earnings data Q4 2022

Earnings data Q1 2023

Earnings data Q2 2023

Earnings data Q3 2023

Earnings data Q4 2023

Earnings data Q1 2024

Earnings data Q2 2024

Earnings data Q3 2024

Earnings data Q4 2024

Clover Health reports profitable Q1, poised for sustained growth

Clover Health Investments had a strong Q1 performance, expecting full-year profitability and revenue growth. With a focus on operational enhancements, revenue growth, and cost reductions, the company aims to maintain momentum in 2024 amidst industry challenges. Clover's strategic initiatives like share repurchase program and product enhancements position it well for sustained growth and care management excellence.

Clover Health achieves profitability milestone and eyes market expansion

Clover Health's Q2 2024 earnings call reflects a positive trajectory with increased profitability, strong revenue growth, and improved guidance for the full year.
The company's strategic focus on operational efficiency, technology innovation, and market validation positions it well for sustainable growth and market expansion.
While facing challenges in maintaining profitability and implementing technology enhancements, Clover Health has opportunities to capitalize on market interest and drive further growth in the Medicare Advantage sector.

Clover Health reports strong Q3 performance and eyes growth opportunities

Clover Health Investments (CLOV) showcased strong financial performance and strategic investments in growth areas during the Q3 2024 earnings call. The company's focus on membership growth, quality initiatives, and technology enhancements, along with exploring health partnerships, highlights a promising outlook for future success.

Revenue

Cost of revenue

Gross profit

Operating expenses

SG&A

Other

Operating income

EBITDA

Net income

Earnings per share

Total assets

Current assets

Cash & equivalents

Receivables

Inventory

Non-current assets

Net PPE

Intangibles

Total liabilities

Current liabilities

Short term debt

Income tax payable

Non-current liabilities

Long-term debt

Total equity

Stockholders equity

Minority interest

Total liabilities & equity

Total debt

Net debt

Book value per share

Cash from operations

Funds from operations

Change in working capital

Cash from investing

Capital expenditure

Purchase/sale of investments

Purchase/sale of business

Other sources

Cash from financing

Change in stock

Change in debt

Cash dividends paid

Cash from other sources

Net change in cash

Free cash flow

Clover Health Investments Corp. is a physician enablement technology company that provides Medicare Advantage plans in the United States. Its strategy is powered by its proprietary software platform, Clover Assistant, which aggregates patient data from across the healthcare ecosystem to support clinical decision-making and improve health outcomes through the early identification and management of chronic diseases. The company offers PPO and HMO Medicare Advantage plans in several states, with a differentiated focus on its flagship wide-network, high-choice PPO plans. Clover Health Investments was founded by Vivek Garipalli and Andrew Toy on July 17, 2014 and is headquartered in Franklin, TN.

FRANKLIN, Tenn., April 30, 2024 (GLOBE NEWSWIRE) -- Clover Health Investments, Corp. (Nasdaq: CLOV) (“Clover” or the “Company”), a physician enablement technology company committed to bringing access to great healthcare to everyone on Medicare, announced today that effective April 29, 2024, the Talent and Compensation Committee of the Company's Board of Directors granted a restricted stock unit award (the “RSUs”) to Peter Kuipers, who will be the Company's new Chief Financial Officer effective as of the day after filing of our Quarterly Report on Form 10-Q for the quarter-ended March 31, 2024. The RSUs were granted under the Company's 2022 Inducement Award Plan (the “Inducement Plan”) and will be subject to the terms and conditions of an award agreement and the Inducement Plan.

Clover Health Announces Inducement Grant under Nasdaq Listing Rule 5635(c)(4)

FRANKLIN, Tenn., April 23, 2024 (GLOBE NEWSWIRE) -- Clover Health Investments, Corp. (NASDAQ: CLOV) (“Clover,” “Clover Health” or the “Company”), today announced that it will report first quarter 2024 financial results after market close on Tuesday, May 7, 2024. Management will host a conference call and webcast at 5:00 p.m. Eastern Time on May 7, 2024, to discuss the Company's business and financial results.

Clover Health to Report First Quarter 2024 Financial Results on May 7, 2024

FRANKLIN, Tenn., April 22, 2024 (GLOBE NEWSWIRE) -- Clover Health Investments, Corp. (NASDAQ: CLOV) (“Clover,” “Clover Health” or the “Company”), a physician enablement technology company, today announced the appointment of Peter Kuipers as Chief Financial Officer (“CFO”), effective as of the day after the filing of the Company's Quarterly Report on Form 10-Q for the quarter-ended March 31, 2024.

Clover Health Appoints Healthcare Technology Veteran Peter Kuipers as Chief Financial Officer

FRANKLIN, Tenn., April 04, 2024 (GLOBE NEWSWIRE) -- As previously disclosed, most recently in its Annual Report on Form 10-K for the fiscal year ended December 31, 2023, and in its Quarterly Report on Form 10-Q for the fiscal quarter ended September 30, 2023, Clover Health Investments, Corp. (the "Company") has reached an agreement to resolve shareholder derivative actions pending in four jurisdictions. The actions are captioned: (1) Sun v. Garipalli, et al., No. 3:21-cv-0311 (M.D. Tenn.); (2) In re: Clover Health Investments Corp. Derivative Litig., No. 1:21-cv-00191 (D. Del.); (3) In re Clover Health Investments, Corp. Stockholder Derivative Litig., Index No. 655420/2021 (N.Y. Sup. Ct., N.Y. Cnty.); and (4) Davies v. Garipalli, et al., No. 2021-1016-SG (Del. Ch.) (collectively the "Shareholder Derivative Actions"). The Shareholder Derivative Actions were filed in the wake of the Company's de-SPAC transaction.

Clover Health Provides Notice Associated with Previously Disclosed Settlement of Shareholder Derivative Actions

Opera Ltd - ADR

SNDL Inc.

Numbers frequently take center stage in the stock market's maze. However, every figure has a story of strategy, ingenuity, and resiliency behind it.

3 Under-the-Radar Stocks to Transform $10K into $100K by 2028

Partnership aims to improve outcomes through increased support to underserved and at-risk patient populations through Clover's home-based care model Partnership aims to improve outcomes through increased support to underserved and at-risk patient populations through Clover's home-based care model

Clover Health Launches New Clinical Program in Partnership with Quartet Health to Address Serious Mental Illness

Clover Health Investments, Corp. (CLOV) Q4 2023 Earnings Call Transcript

Full-year 2023 Insurance MCR improved to 81.2% and fourth quarter MCR to 82.4% Company improves full-year 2023 Net Loss by $126.2 million and full-year Adjusted EBITDA by $245.7 million year-over-year Issues 2024 guidance with Insurance MCR range of 79% - 83% and up to $20 million of Adjusted EBITDA profitability at the high end of the range FRANKLIN, Tenn., March 12, 2024 (GLOBE NEWSWIRE) -- Clover Health Investments, Corp. (NASDAQ: CLOV) ("Clover," "Clover Health" or the "Company"), a managed care company focused on physician enablement, today reported financial results for the fourth quarter and full year 2023.

Clover Health Reports Fourth Quarter and Full Year 2023 Financial Results; Delivers Continued Momentum in Financial Performance and Provides Full-Year 2024 Guidance

Mr. Thornton brings a decade of Medicare Advantage leadership experience Mr. Thornton brings a decade of Medicare Advantage leadership experience

Industry Veteran Clay Thornton Joins Clover Health as CFO of Medicare Advantage

FRANKLIN, Tenn., Feb. 26, 2024 (GLOBE NEWSWIRE) -- Clover Health Investments, Corp. (NASDAQ: CLOV) (“Clover,” “Clover Health” or the “Company”), today announced that it will report fourth quarter and full year 2023 financial results after market close on Tuesday, March 12, 2024. Management will host a conference call and webcast at 5:00 p.m. Eastern Time on March 12, 2024 to discuss the Company's business and financial results.

Clover Health to Report Fourth Quarter and Full Year 2023 Financial Results on March 12, 2024

Blade Air Mobility

In the stock market, identifying penny stocks with massive growth potential is similar to walking on a rope between two skyscrapers. Penny stocks offer high potential returns.

3 Under-the-Radar Penny Stocks With 1,000% Growth Potential by 2026

Bitfarms Ltd

Nikola

There are some hidden-gem penny stocks for investors to tap into amid the broader indices, such as the S&P 500 and the Nasdaq moving higher. What goes on in the macro environment can sway the companies' valuations, which could lead to substantial gains for investors.

3 Hidden-Gem Penny Stocks Ready to Ride a Massive Market Wave

ACM Research

Nkarta, Inc.

Some stocks silently position themselves for monumental bursts. These companies, spanning the semiconductor, healthcare and biotechnology sectors, are emerging as unseen giants with the potential for a 10X surge.

Unseen Giants: 3 Stocks Quietly Preparing for a 10X Surge

Zomedica

In the volatile space of penny stocks, three companies are emerging as powerhouses with breakout potential, poised for massive gains. To begin with, the first one's organic growth, the second one's data licensing prowess in liquor retail, and the third one's strategic insurance advancements are captivating the market.

3 Breakout Penny Stocks Primed for Massive Gains

Benchmark Electronics

Ceragon Networks

A handful of companies in the volatile stock market hold the elusive key to uncharted growth. Fortunes rise and fall here, and the hunt for exceptional investments never ceases.

3 Once-in-a-Lifetime Stocks on the Verge of an Unprecedented Surge

FRANKLIN, Tenn., Jan. 10, 2024 (GLOBE NEWSWIRE) -- Clover Health Investments, Corp. (NASDAQ: CLOV) (“Clover,” “Clover Health” or the “Company”), a physician enablement company committed to bringing access to great healthcare to everyone on Medicare, announced today that it is targeting Adjusted EBITDA profitability for the full-year 2024. (1)

Clover Health Provides Business Update and Full-Year 2024 Objectives

Higher fill rates result in improved performance on medication adherence quality measures in the Medicare Advantage Stars program for members where Clover Assistant was used Higher fill rates result in improved performance on medication adherence quality measures in the Medicare Advantage Stars program for members where Clover Assistant was used

PCP Use of Clover Assistant Correlated with Increased Medication Fills for Patients who Were Previously Non-Adherent

P3 Health Partners Inc

Talkspace

Zacks Medical Info Systems industry stocks like Clover Health Investments (CLOV), Talkspace (TALK) and P3 Health Partners (PIII) are expected to gain from the new normal trends.

3 Medical Info Systems Stocks to Buy as Industry Rebounds

Clover Health Investments, Corp. (CLOV) has been upgraded to a Zacks Rank #2 (Buy), reflecting growing optimism about the company's earnings prospects. This might drive the stock higher in the near term.

Clover Health Investments, Corp. (CLOV) Upgraded to Buy: Here's Why

Clover Health Investments (NASDAQ: CLOV ) stock is gaining on Thursday after the medicare advantage plans company announced the departure of its Chief Financial Officer. Scott Leffler, current CFO of Clover Health Investments, will be leaving the company on Jan. 26, 2024.

CLOV Stock Alert: Clover Health Announces CFO Departure

Lee A. Shapiro, Clover Audit Committee Chair, will lead the search for the next Clover CFO Lee A. Shapiro, Clover Audit Committee Chair, will lead the search for the next Clover CFO

Clover Health Announces Departure of Chief Financial Officer; Reiterates Most Recently Issued Financial Guidance for 2023

FRANKLIN, Tenn., Dec. 18, 2023 (GLOBE NEWSWIRE) -- Clover Health Investments, Corp. (NASDAQ: CLOV) (“Clover,” “Clover Health” or the “Company”), a physician enablement company committed to bringing access to great healthcare to everyone on Medicare, today announced that its CEO, Andrew Toy, will present at the 42nd Annual J.P. Morgan Healthcare Conference on Thursday, January 11, 2024, at 12:00 p.m. Eastern Time.

Clover Health to Present at 42nd Annual J.P. Morgan Healthcare Conference on January 11, 2024

FRANKLIN, Tenn., Dec. 01, 2023 (GLOBE NEWSWIRE) -- Clover Health Investments, Corp. (NASDAQ: CLOV) (“Clover,” “Clover Health” or the “Company”), a physician enablement company committed to bringing access to great healthcare to everyone on Medicare, today announced that it has delivered notice to the Centers for Medicare and Medicaid Services (“CMS”) that it will exit the CMS ACO REACH Program at the end of the 2023 performance year. Written notification will also be sent to all participating physicians in accordance with CMS requirements. The decision will have no impact on its ACO REACH beneficiaries, and Clover will continue to fulfill all of its obligations under the ACO REACH Program for the 2023 performance year.

Clover Health Exits ACO REACH to Accelerate Path to Profitability

SunCoke Energy

In the ever-evolving landscape of the stock market, identifying undervalued stocks with exponential growth potential is akin to discovering hidden gems. Amidst this pursuit, three stocks under $10 emerge as promising contenders in their respective industries.

Tomorrow's Titans: 3 Stocks Under $10 Poised for Explosive Growth

ATLANTA , Nov. 7, 2023 /PRNewswire/ -- Clover Health and WellBe Senior Medical have teamed up to deliver home-based medical care to residents of Georgia living with multiple complex health conditions. By providing a new option for home-based medical care, Clover is helping its members achieve their health goals with access to quality care through WellBe's in-home visits.

News for Clover Health Investments Stock (CLOV)